Literature DB >> 24874610

Effect of a Pulmonary Rehabilitation Program on the levels of anxiety and depression and on the quality of life of patients with chronic obstructive pulmonary disease.

C C da Costa1, C de Azeredo Lermen2, C Colombo3, D B Canterle4, M L L Machado5, A Kessler6, P J Z Teixeira7.   

Abstract

OBJECTIVE: To analyze the effect of a Pulmonary Rehabilitation Program (PRP) on the levels of anxiety and depression and the quality of life of patients with chronic obstructive pulmonary disease.
METHOD: Patients with chronic obstructive pulmonary disease (COPD) who completed the PRP of 3 weekly sessions of 60 min duration for 12 weeks, a total of 36 sessions, were assessed using Beck Inventory (BAI and BDI) and Saint George's Respiratory Questionnaire (SGRQ).
RESULTS: A total of 125 individuals, with an average age of 63.7 ± 8.8 years, FEV1: 1.17 ± 0.57L (43.18 ± 18.79% predicted), 61.6% male and 38.4% female, were analyzed. The BAI and BDI before and after PRP were, respectively, 10.15 ± 6.32 vs. 7.67 ± 7.21; p=0.0041 and 12.60 ± 7.99 vs. 8.96 ± 7.29; p=0.00016. The results of the SGRQ domains were, respectively, Before and After symptoms (48.53 ± 20.41 vs. 32.58 ± 18.95), Activity (69.15 ± 20.79 vs. 52.42 ± 23.70), Impact (32.92 ± 18.29 vs. 20.27 ± 16.70), Total (46.69 ± 16.90 vs. 32.07 ± 16.96). When correlating the BDI to the domains of the SGRQ, weak correlations were observed (Symptoms r=0.22; p=0.01; Activity r=0.28; p=0.001; Impact r=0.52; p=2.72; Total r=0.44; p=0.17). In the same way, weak correlations were observed when correlating the BAI to the SGRQ (Symptoms r=0.28; p=0.0009; Activity r=0.32; p=0.0005; Impact r=0.42; p=7.33; Total r=0.43; p=0.74).
CONCLUSION: Although the PRP improves levels of depression and anxiety as well as the quality of life in patients with COPD, no significant correlation of these analyzed variables was observed.
Copyright © 2013 Sociedade Portuguesa de Pneumologia. Published by Elsevier España. All rights reserved.

Entities:  

Keywords:  Ansiedade; Anxiety; COPD; DPOC; Depression; Depressão; Pulmonary rehabilitation; Qualidade de vida; Quality of life; Reabilitação pulmonar

Mesh:

Year:  2014        PMID: 24874610     DOI: 10.1016/j.rppneu.2014.03.007

Source DB:  PubMed          Journal:  Rev Port Pneumol        ISSN: 0873-2159


  5 in total

1.  Effects of pulmonary rehabilitation in patients with mild-to-moderate chronic obstructive pulmonary disease: Bottom of an iceberg.

Authors:  Pervin Korkmaz Ekren; Alev Gürgün; Funda Elmas Uysal; Şenay Tuncel; Sami Deniz; Hale Karapolat; Feza Bacakoğlu
Journal:  Turk J Phys Med Rehabil       Date:  2018-05-23

Review 2.  Strategies to improve anxiety and depression in patients with COPD: a mental health perspective.

Authors:  Athanasios Tselebis; Argyro Pachi; Ioannis Ilias; Epaminondas Kosmas; Dionisios Bratis; Georgios Moussas; Nikolaos Tzanakis
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-09       Impact factor: 2.570

3.  An observational cohort study of exercise and education for people with chronic obstructive pulmonary disease not meeting criteria for formal pulmonary rehabilitation programmes.

Authors:  A Lewis; D Dullaghan; H Townes; A Green; J Potts; Jennifer K Quint
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

Review 4.  Exercise Training in Patients with Chronic Respiratory Diseases: Are Cardiovascular Comorbidities and Outcomes Taken into Account?-A Systematic Review.

Authors:  Ana Machado; Kirsten Quadflieg; Ana Oliveira; Charly Keytsman; Alda Marques; Dominique Hansen; Chris Burtin
Journal:  J Clin Med       Date:  2019-09-13       Impact factor: 4.241

5.  Assessment of Stress, Depressive and Anxiety Symptoms in Patients with COPD during In-Hospital Pulmonary Rehabilitation: An Observational Cohort Study.

Authors:  Adam Wrzeciono; Oliver Czech; Katarzyna Buchta; Sabina Zabłotni; Edyta Gos; Łukasz Tłuczykont; Dagmara Górecka; Agnieszka Pastuła; Mateusz Adamczyk; Ewa Jach; Igor Świerkowski; Patryk Szary; Jan Szczegielniak
Journal:  Medicina (Kaunas)       Date:  2021-02-25       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.